Theranautilus is a national award-winning medical hardware company specializing in the design and deployment of nanorobots for healthcare. Focused on safe drug delivery and microsurgical therapies, their patented device enables precise targeting within the human body. With a unique approach, they cater to both B2B and B2C markets, offering specialized oral health solutions and licensing their technology to dental companies. Their mission is to address critical healthcare challenges, including AMR bacterial infections and cancer therapeutics, using proprietary nanorobots. The company is advancing rapidly towards human clinical trials and remains committed to improving global health through deep tech innovation.